Official Publications Sanofi

Equities

Real-time Euronext Paris Other stock markets 09:28:20 2025-07-15 am EDT			5-day change	1st Jan Change
83.54 ^EUR	0.00%		+0.23%	-10.90%

Jul. 11	SANOFI : UBS reiterates its Buy rating	ZD
Jul. 10	Delaware Supreme Court sides with Zantac drugmakers over cancer evidence	RE

Monthly statement of shares and voting rights	Jun. 29	CO
Monthly statement of shares and voting rights	Jun. 29	CO
Director/PDMR/Person closely associated - Purchase/Subscription	Jun. 26	CO
Share buyback	Jun. 22	CO
Acquisition	Jun. 01	CO
Acquisition	Jun. 01	CO
Monthly statement of shares and voting rights	May. 30	CO
Monthly statement of shares and voting rights	May. 30	CO
Acquisition	May. 26	CO
Acquisition	May. 26	CO
Director/PDMR/Person closely associated - Purchase/Subscription	May. 05	CO
Share buyback	May. 01	CO
Share buyback	May. 01	CO
Monthly statement of shares and voting rights	Apr. 29	CO
Monthly statement of shares and voting rights	Apr. 29	CO
Minutes of the general assembly	Apr. 29	CO
Minutes of the general assembly	Apr. 29	CO
1st quarter turnover	Apr. 23	CO
1st quarter turnover	Apr. 23	CO
Security operations	Apr. 17	CO
Security operations	Apr. 17	CO
Mixed general shareholder meeting	Apr. 08	CO
Director/PDMR/Person closely associated - Purchase/Subscription	Apr. 01	CO
Monthly statement of shares and voting rights	Mar. 30	CO
Monthly statement of shares and voting rights	Mar. 30	CO

SANOFI : Pipeline disappointments may push out the CEO

July 01, 2025 at 01:56 pm EDT

Trump wants to reduce drug prices by up to 80%

May 12, 2025 at 04:45 am EDT

Sanofi : The Doliprane case

October 18, 2024 at 09:16 am EDT

Paul Hudson, CEO of Sanofi: AI to improve organisational efficiency